Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL970730 | 1.00 | ALDH1A1 (0.32) | ALDH1A1TSHR | |
| SCHEMBL6751593 | 1.00 | ALDH1A1 (0.32) | ALDH1A1TSHR | |
| SCHEMBL9108099 | 1.00 | ALDH1A1 (0.32) | ALDH1A1TSHR | |
| SCHEMBL1719880 | 0.97 | ALDH1A1 (0.30) | ALDH1A1TSHR | |
| SCHEMBL29105368 | 0.87 | TSHR (0.40) | ALDH1A1TSHR | |
| SCHEMBL15541793 | 0.82 | ALDH1A1 (0.33) | ALDH1A1TSHR | |
| SCHEMBL8665942 | 0.82 | ALDH1A1 (0.33) | ALDH1A1TSHR | |
| SCHEMBL5323576 | 0.79 | — | — | |
| SCHEMBL1446445 | 0.78 | ALDH1A1 (0.35) | ALDH1A1TSHR | |
| SCHEMBL9734937 | 0.76 | TSHR (0.36) | ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024071414-A1 | SURFACE TREATMENT AGENT | ダイキン工業株式会社 | 2024-04-04 | — | — | WO | disclosed |
| US-9884970-B2 | Coating composition for preventing collapse of capacitor | YOUNG CHANG CHEMICAL CO., LTD (KR) | 2018-02-06 | — | — | US | disclosed |
| EP-2468798-B1 | SOLID ELECTROLYTE MEMBRANE FOR FUEL CELL AND PROCESS FOR PRODUCING SAME | CENTRAL GLASS CO LTD (JP) | 2017-03-08 | — | — | EP | disclosed |
| US-20150274991-A1 | COATING COMPOSITION FOR PREVENTING COLLAPSE OF CAPACITOR | YOUNG CHANG CHEMICAL CO., LTD (KR) | 2015-10-01 | — | — | US | disclosed |
| WO-2014092424-A1 | COATING COMPOSITION FOR PREVENTING COLLAPSE OF CAPACITOR | 영창케미칼 주식회사 (KR) | 2014-06-19 | — | — | WO | disclosed |
| US-8445551-B2 | Solid electrolyte membrane for fuel cell and process for producing same | CENTRAL GLASS COMPANY, LTD. (JP) | 2013-05-21 | — | — | US | disclosed |
| EP-2468798-A1 | SOLID ELECTROLYTE MEMBRANE FOR FUEL CELL AND PROCESS FOR PRODUCING SAME | Central Glass Company, Limited (JP) | 2012-06-27 | — | — | EP | disclosed |
| US-20120142791-A1 | Solid Electrolyte Membrane for Fuel Cell and Process for Producing Same | CENTRAL GLASS COMPANY, LIMITED (JP) | 2012-06-07 | — | — | US | disclosed |
| US-7498293-B2 | Alkylaminosiloxanes as corrosion inhibitors | CIBA SPECIALTY CHEMICALS CORP. (US) | 2009-03-03 | — | — | US | disclosed |
| US-20050176596-A1 | Alkylaminosiloxanes as corrosion inhibitors | CIBA SPECIALTY CHEMICAL CORP. | 2005-08-11 | — | — | US | disclosed |
| EP-1509534-A2 | ALKYLAMINOSILOXANES AS CORROSION INHIBITORS | Ciba SC Holding AG (CH) | 2005-03-02 | — | — | EP | disclosed |
| WO-2003101947-A2 | ALKYLAMINOSILOXANES AS CORROSION INHIBITORS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2003-12-11 | — | — | WO | disclosed |
| US-5463058-A | Light, heat and oxidation stabilizers for synthetic polymers | CIBA-GEIGY CORPORATION (US) | 1995-10-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120142791-A1 | Solid Electrolyte Membrane for Fuel Cell and Process for Producing Same | LNPK, KCNJ1, EPCAM | ALDH1A1 2851/4885TSHR 4140/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.